Skip to main content

Want a detailed portfolio tracker?

Editas Medicine (EDIT) P/E (2016 - 2026)

Editas Medicine (EDIT) P/E from Mar 31, 2016 to Jul 21, 2026. The TTM Editas Medicine (EDIT) P/E is -2.43. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Editas Medicine (EDIT)

YearP/EChange
2026-2.43+118.35%
2025-1.11+151.55%
2024-0.44-88.50%
2023-3.84+26.85%
2022-3.03-67.74%
2021-9.38-74.02%
2020-36.12+220.07%
2019-11.28+14.81%
2018-9.83+0.60%
2017-9.77-1.70%
2016-9.94N/A

Comparison Editas Medicine (EDIT) P/E with competitors

Editas Medicine (EDIT) P/E is -2.43.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.18%
ENLVEnlivex Ltd0.07-103.08%
FGENFibroGen Inc0.24-109.89%
CHRSCoherus Biosciences Inc0.85-134.97%
FBIOFortress Biotech Inc0.95-139.11%
ORMPOramed Pharmaceuticals Inc1.50-161.95%
AGENAgenus Inc3.01-224.04%
INVAInnoviva Inc3.15-229.99%
VXRTVaxart Inc3.55-246.30%
CRMDCorMedix Inc3.63-249.54%
CVACCureVac N.V.4.45-283.22%
GLPGGalapagos NV4.86-300.25%
SRPTSarepta Therapeutics Inc4.88-301.21%
ABEOAbeona Therapeutics Inc5.39-322.04%
ABUSArbutus Biopharma Corp5.60-330.62%
ZVRAZevra Therapeutics Inc5.89-342.64%
SPROSpero Therapeutics Inc6.23-356.70%
CGENCompugen Ltd6.31-360.22%
RIGLRigel Pharmaceuticals6.87-383.23%
SLXNSilexion Therapeutics Corp7.30-400.70%
OMEROmeros Corporation9.26-481.59%
AUPHAurinia Pharmaceuticals Inc9.58-495.03%
PLXProtalix BioTherapeutics Inc10.89-548.86%
ACADAcadia Pharmaceuticals Inc11.73-583.38%
TBPHTheravance Biopharma Inc12.26-605.37%
ADMAAdma Biologics Inc12.42-611.80%
HRMYHarmony Biosciences Holdings Inc13.82-669.59%
SABSSAB Biotherapeutics Inc14.14-682.61%
NAGENiagen Bioscience Inc14.82-710.72%
INCYIncyte Corp15.82-752.11%
REGNRegeneron Pharmaceuticals Inc15.86-753.52%
PBYIPuma Biotechnology Inc17.32-813.65%
CPRXCatalyst Pharmaceuticals Inc17.44-818.75%
EXELExelixis Inc17.54-822.81%
TGTXTG Therapeutics Inc18.97-881.67%
MDXGMimedx Group Inc20.55-947.05%
XOMAXOMA Royalty Corp22.87-1042.79%
ARGXArgen X SE24.30-1101.45%
CTMXCytomX Therapeutics Inc24.82-1123.01%
XOMAOXOMA Royalty Corp25.34-1144.59%
HALOHalozyme Therapeutics Inc25.62-1156.09%
XOMAPXOMA Royalty Corp25.67-1158.00%
VRTXVertex Pharmaceuticals Inc27.99-1253.81%
RPRXRoyalty Pharma plc - Class A28.69-1282.36%
SLNOSoleno Therapeutics Inc29.02-1295.87%
ASNDAscendis Pharma A/S30.09-1339.98%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1662.55%
APLSApellis Pharmaceuticals Inc39.02-1708.27%
BMRNBiomarin Pharmaceutical Inc42.21-1839.77%
KRYSKrystal Biotech Inc45.34-1968.84%
ONCBeiGene Ltd69.54-2966.13%
PHARPharming Group N.V.75.03-3192.20%
TECHBio-Techne Corp101.96-4302.24%
VCELVericel Corp109.92-4630.44%
ALNYAlnylam Pharmaceuticals Inc117.96-4961.96%
GMABGenmab140.29-5882.12%
TLXTelix Pharmaceuticals Ltd162.15-6783.17%
CORTCorcept Therapeutics Inc212.86-8872.98%